Psoriasis treatment is associated with a reduced risk of some infections and improved survival in patients with end-stage kidney disease (ESKD), according to recent study findings.
Patients with ESKD and psoriasis may be at greater risk for infection due to chronic vascular access and epidermal dysfunction, in addition to other factors, Wendy B. Bollag, PhD, of the Medical College of Georgia at Augusta University, and colleagues explained.
Of 866,828 patients on hemodialysis or peritoneal dialysis in the 2004-2011 US Renal Data System (USRDS), 8911 (1.0%) had psoriasis. In adjusted analyses, a psoriasis diagnosis, compared with no psoriasis diagnosis, was significantly associated with an increased risk for 9 common infections in the ESKD population.
Psoriasis treatment significantly reduced the risk of some of these infections and was associated with improved survival, Dr. Bollag and her peers reported in The American Journal of the Medical Sciences.
Click the button below to learn more.